City

Rionero in Vulture (1)

Shanghai (1)

Wuhan (1)

Condition

Primary Plasma Cell Leukemia (3)

Multiple Myeloma (2)

Extramedullary Multiple Myeloma (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

early phase 1 (1)

Sponsor

IRCCS Centro di Riferimento Oncologico della Basilicata (1)

Shanghai Changzheng Hospital (1)

Wuhan Union Hospital, China (1)

Collaborator

CARsgen Therapeutics Co., Ltd. (1)

Celgene Corporation (1)

Study Documents

Intervention Type

drug (3)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (3)

primary plasma cell leukemia

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting

Multiple Myeloma
+2 more

Daratumumab
+10 more

Wuhan, Hubei, China

Institute of Hematology, Union Hospital, Tongji Medical College,

Nov 18, 2023

Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)

Not yet recruiting

Multiple Myeloma
Primary Plasma Cell Leukemia

Experimental: CAR-T cells Infusion

Shanghai, China

Shanghai Changzheng Hospital

Apr 20, 2023

Primary Plasma Cell Leukemia Trial in Rionero in Vulture (Lenalidomide, dexamethasone)

Completed

Primary Plasma Cell Leukemia

Lenalidomide, dexamethasone

Rionero in Vulture, Pz, Italy

IRCCS - CROB Ethic Committee

Mar 13, 2012